Deutsche Bank’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.25M | Sell |
236,192
-130,488
| -36% | -$2.62M | ﹤0.01% | 1381 |
|
|
2025
Q4 | $8.59M | Buy |
366,680
+204,421
| +126% | +$4.43M | ﹤0.01% | 1135 |
|
|
2025
Q3 | $3.24M | Buy |
162,259
+137,651
| +559% | +$2.47M | ﹤0.01% | 1504 |
|
|
2025
Q2 | $337K | Sell |
24,608
-2,574
| -9% | -$24.7K | ﹤0.01% | 2665 |
|
|
2025
Q1 | $301K | Sell |
27,182
-4,081
| -13% | -$43.5K | ﹤0.01% | 2755 |
|
|
2024
Q4 | $333K | Buy |
31,263
+11,916
| +62% | +$143K | ﹤0.01% | 2839 |
|
|
2024
Q3 | $246K | Buy |
19,347
+5,058
| +35% | +$75.1K | ﹤0.01% | 2823 |
|
|
2024
Q2 | $240K | Buy |
14,289
+1,205
| +9% | +$17.1K | ﹤0.01% | 2706 |
|
|
2024
Q1 | $196K | Buy |
13,084
+2,716
| +26% | +$44.4K | ﹤0.01% | 2826 |
|
|
2023
Q4 | $156K | Sell |
10,368
-146
| -1% | -$1.9K | ﹤0.01% | 3004 |
|
|
2023
Q3 | $147K | Buy |
10,514
+9,143
| +667% | +$147K | ﹤0.01% | 2970 |
|
|
2023
Q2 | $14.2K | Buy |
+1,371
| New | +$15.1K | ﹤0.01% | 3620 |
|
|
2022
Q2 | – | Sell |
-11,278
| Closed | -$98K | – | 4345 |
|
|
2022
Q1 | $98K | Sell |
11,278
-1,260
| -10% | -$9.82K | ﹤0.01% | 3587 |
|
|
2021
Q4 | $120K | Buy |
12,538
+630
| +5% | +$8.88K | ﹤0.01% | 3627 |
|
|
2021
Q3 | $201K | Sell |
11,908
-365
| -3% | -$5.79K | ﹤0.01% | 3568 |
|
|
2021
Q2 | $188K | Sell |
12,273
-981
| -7% | -$17.7K | ﹤0.01% | 3824 |
|
|
2021
Q1 | $258K | Sell |
13,254
-3,894
| -23% | -$82.7K | ﹤0.01% | 3498 |
|
|
2020
Q4 | $309K | Buy |
17,148
+4,044
| +31% | +$84.7K | ﹤0.01% | 3213 |
|
|
2020
Q3 | $252K | Buy |
13,104
+942
| +8% | +$21.3K | ﹤0.01% | 3096 |
|
|
2020
Q2 | $317K | Buy |
12,162
+5,534
| +83% | +$135K | ﹤0.01% | 2878 |
|
|
2020
Q1 | $119K | Sell |
6,628
-741
| -10% | -$20K | ﹤0.01% | 3175 |
|
|
2019
Q4 | $244K | Buy |
7,369
+1,532
| +26% | +$41.8K | ﹤0.01% | 3099 |
|
|
2019
Q3 | $138K | Sell |
5,837
-3,457
| -37% | -$113K | ﹤0.01% | 3392 |
|
|
2019
Q2 | $333K | Buy |
9,294
+105
| +1% | +$3.87K | ﹤0.01% | 3527 |
|
|
2019
Q1 | $338K | Sell |
9,189
-6,421
| -41% | -$269K | ﹤0.01% | 3687 |
|
|
2018
Q4 | $672K | Sell |
15,610
-6,969
| -31% | -$313K | ﹤0.01% | 3137 |
|
|
2018
Q3 | $1.07M | Buy |
22,579
+10,500
| +87% | +$488K | ﹤0.01% | 3286 |
|
|
2018
Q2 | $601K | Sell |
12,079
-17,580
| -59% | -$1.02M | ﹤0.01% | 3746 |
|
|
2018
Q1 | $1.47M | Sell |
29,659
-21,008
| -41% | -$1.05M | ﹤0.01% | 3073 |
|
|
2017
Q4 | $1.89M | Buy |
50,667
+34,291
| +209% | +$1.22M | ﹤0.01% | 2763 |
|
|
2017
Q3 | $516K | Buy |
16,376
+8,816
| +117% | +$195K | ﹤0.01% | 3409 |
|
|
2017
Q2 | $136K | Buy |
+7,560
| New | +$131K | ﹤0.01% | 4099 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
